CLIA Regulations and Regulatory Framework
What this domain tests
The CLIA Regulations and Regulatory Framework domain asks how CLIA '88 is implemented and who oversees it. CLIA is a federal law; its laboratory requirements sit at 42 CFR Part 493. CMS administers the program, CDC supplies scientific and technical support, and FDA categorizes test complexity. CLIA covers laboratories that examine human specimens to diagnose, prevent, treat, or assess disease. Research-only laboratories that do not report patient results, forensic testing, and certain other categories fall outside its scope.
Core rules
- A laboratory must hold the correct CLIA certificate before testing patient specimens: certificate of waiver, certificate for provider-performed microscopy (PPM), certificate of compliance, or certificate of accreditation.
- Accreditation is not a substitute for CLIA; it is a path to deemed status, and CMS retains oversight.
- The laboratory director is accountable for overall operation and compliance.
- State licensure or stricter state rules can apply on top of CLIA.
Worked example
A physician office performs only an FDA-cleared urine pregnancy dipstick and records results in the chart. The manager says, 'It is waived, so we do not need a CLIA certificate.' Reasoning: waived status lowers requirements but does not remove the certificate requirement. The office needs a certificate of waiver, must follow the manufacturer's instructions, and must permit inspection. If it adds a moderate-complexity chemistry test, the waiver certificate is insufficient.
Traps that cost marks
Assuming 'waived' means 'no CLIA.' Confusing CMS, CDC, and FDA roles. Treating accreditation as outside CLIA. Forgetting that state law may be stricter.